Please login to the form below

Not currently logged in
Email:
Password:

Biomunex appoints scientific and strategic advisors

Dr Sebastian Amigorena and Dr Dragan Grabulovski

Biomunex Dr Sebastian AmigorenaParis, France-based immuno-oncology specialist Biomunex Pharmaceuticals has appointed Dr Sebastian Amigorena and Dr Dragan Grabulovski as key scientific advisor and key strategic advisor, respectively.

Dr Amigorena (pictured right) is currently a research director at Le Centre National de la Recherché Scientifique (CNRS) and is director of the Inserm Immunity and Cancer Unit at the Institut Curie in Paris.

In his role as scientific advisory, he will help the company to leverage its 'Plug-and-Play' antibody platform for the development of Biomunex's immunotherapeutics pipeline.

Biomunex Dr Dragan GrabulovskiMeanwhile, Dr Grabulovski (pictured left) is a pharmaceutical biotechnology advisor at Grabulovski Consulting Services, having previously served as chief scientific officer of Covagen, which he co-founded.

Prior to Covagen's sales to Johnson & Johnson in 2014, Dr Grabulovski was responsible for the Swiss biotech's research and development strategy, including its Fynomer technology.

Dr Pierre-Emmanuel Gerard, chief executive officer at Biomunex, said: “We are very pleased to welcome Dr Amigorena and Dr Grabulovski as key advisors.

“As international key opinion leaders they will play an instrumental role as we advance our first oncology programmes into pre-clinical and clinical development."

22nd December 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is part of Creston Unlimited (www.creston-unlimited.com), bringing together consultants and discipline experts from across the group and beyond....

Latest intelligence

Medius Deal Watch
Deal Watch December 2016
Allergan, AZ, BMS, Pfizer, Roche and more feature in this month's pharma deals round-up...
The Young Dementia Network - much more than a logo
Welcome to the second and final part of my two-part blog....
Patient-centred care innovation in dementia: a conversation with Neil Maiden
Content Marketing Manager Liz Inskip interviews Neil Maiden of City, University of London, about his work developing mobile technology solutions for residential dementia care, and what the challenges facing innovators...

Infographics